Naturally occurring anti-E, present without obvious antigenic stimulation is a rare occurrence of red cell antibody of the Rh blood group system. It is mentioned that such naturally occurring anti-E react only with enzyme modified E-positive red cells. This case report describes a rare case of naturally occurring anti-E in a patient with autoimmune haemolytic anaemia (AIHA).
Bangladesh Journal of Medical Science Vol.18(4) 2019 p.818-819
Anti-E antibody is one of the frequently encountered alloantibody of the Rh blood group system; however, it is seldom implicated in haemolytic disease of the foetus and newborn (HDFN). This case report describes a mild HDFN due to anti-E antibody in a full term baby-girl born to a primigravida patient. The baby developed jaundice on the first day of life. Blood group of both mother and the baby was B positive and Rh phenotype was CDe/CDe (R1R1) and CDe/cDE (R1R2) respectively. Anti-E and anti-c was identified in the mother while babys blood showed weak positive Direct Antiglobulin Test with anti-E identified from the babys serum. The baby was started on phototherapy and was discharged well on day-6. Although this was a mild HDFN, we would like to highlight the importance of antenatal screening for pregnant mothers. The antibody screening for Rh-positive mothers is not a routine practice in many centers in Malaysia due to cost-benefit constraints. However, we would like to suggest to include the antenatal red cell antibody screening test for all pregnant mothers at least during the 1st antenatal booking to enable early detection of alloantibody which may cause HDFN, thus enable close monitoring of foetus and initiate early management as needed.Bangladesh Journal of Medical Science Vol.15(1) 2016 p.139-141
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.